YOLFTbeta
01

Samik Pharm.

014950 · KQ · Healthcare / Biotechnology

8,470.00KRW+170.00 (+2.05%)

Price History

Full chart

Market Stats

Previous Close8,300.00
Open8,300.00
Day Range8,090.00 – 8,820.00
52-Week Range3,705.00 – 24,974.09
Volume1.90M
Market Cap80.58B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.47%
50-Day Avg6,712.60
200-Day Avg9,958.20

About

Samik Pharmaceutical Company LTD. develops and manufactures pharmaceuticals. The company offers oral therapeutic pharmaceuticals. It also provides drug compounds, drug delivery systems, drug repositioning, and reinforcement of biopharmaceuticals. The company was founded in 1973 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOChoong-Hwan Lee
  • Headquarters15th floor A Tower, Seoul, South Korea, 05836, Korea
  • Websitehttps://www.samik.co.kr

Leadership

  • Choong-Hwan LeeCEO & Chairman
  • Young Ee KwonCEO, CTO & Director
  • Yong-seok LeeVP & Director

Financials

Income Statement

Currency: KRW2024-12-312025-12-31
Total Revenue-60.02B
Cost of Revenue-17.66B
Gross Profit-42.36B
Gross Margin-70.58%
Operating Expense-39.09B
Operating Income3.68B3.27B
Operating Margin-5.45%
EBITDA-1.45B
EBITDA Margin-2.42%
Net Income3.52B-754.89M
Net Income Margin--1.26%
R&D-2.06B
R&D as % of Total Revenue-3.43%
Interest Expense-29.22M
Interest Expense % of Total Revenue-0.05%

Balance Sheet

Currency: KRW2023-12-312024-12-312025-12-31
Total Assets--85.22B
Total Liabilities--16.24B
Total Equity-51.95B68.98B
Cash--5.22B

Cash Flow

Currency: KRW2024-12-312025-12-31
Operating Cash Flow-2.08B
Capital Expenditure03.43B
Free Cash Flow--1.35B
Dividends Paid-285.97M
FCF to OCF--65.25%
Dividend Paid to FCF--21.11%

Earnings

Report DateMar 31, 2026
EPS Estimate-
EPS Actual127.48
Surprise-
Timing-

Key Statistics & Ratios

Market Cap80.58B
Enterprise Value58.95B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.29
Price / Book1.25
Revenue (TTM)62.26B
Gross Profit (TTM)42.91B
EBITDA3.14B
Profit Margin-2.41%
Operating Margin-1.45%
Return on Equity-2.37%
Return on Assets1.48%
Shares Outstanding9.22M
Shares Float3.94M
Dividend Yield0.47%
Dividend Rate40.00
Payout Ratio31.38%

Dividends

20251×
40.00Dec 29, 2025